
Trends In FDA FY 2024 Inspection-Based Warning Letters
By Liz Oestreich, Kalah Auchincloss, and Erin Hartmann, Eliquent Life Sciences The U.S. FDA issued a total of 190 warning letters to drug and biologics manufacturers in Fiscal Year 2024 (FY24). Of those, 113 were based on an FDA inspection, including 12 …